weight loss
-
anti-obesity medicine, antipsychotics, bipolar disorder, British Journal of Psychiatry Open, Editor Simon Bradstreet, GLP-1 receptor agonists, GLP1, meta-analysis, metabolic health, mortality gap, obesity, physical health, psychosis, schizophrenia, semaglutide, systematic review, tirzepatide, weight gain, weight lossNew heavyweight contender against antipsychotic weight gain? Semaglutide enters the ring
Antipsychotics can be life-changing medications, but they often come with an unwelcome…
